Evaluation of the Making Proud Choices! Teen Pregnancy Prevention Program

Status Completed

Clinical Trial Summary

Under contract to the Office of Population Affairs (OPA), Mathematica is conducting an impact study of the Making Proud Choices! (MPC) teen pregnancy prevention program. The impact study is designed to estimate the impact of MPC, compared to the business-as-usual condition, on risk and protective factors, sexual behaviors, and longer term health goals including pregnancy and sexually transmitted infections.

Clinical Trial Description

This evaluation used a cluster randomized controlled trial (RCT) design to assess the effectiveness of MPC, with schools within districts randomly assigned to one of two conditions: (1) MPC implemented by health educators, or (2) business as usual. In total, 31 school clusters were randomly assigned to condition, including roughly 2800 students, in four geographic areas across the U.S. The study was implemented over the course of three school years (2016-17, 2017-18 and 2018-19), with youth in each year considered a separate evaluation cohort, and with participating schools (and new cohorts of eligible youth) randomized to condition each year. There are two main sources of data for this study: outcome and implementation data. Youth in the study completed two waves of self-report surveys: (1) a baseline survey administered before programming began, and (2) a follow-up outcome survey administered approximately six months after the end of programming (approximately 9 months after baseline, on average). The surveys measured antecedents to sexual behavior (risk and protective factors), sexual behaviors, and ultimately, MPC's health goals of reducing sexually transmitted infections and teen pregnancies. Program implementation data included fidelity and attendance logs, observations, interviews, study youth focus groups, staff surveys, and technical assistance logs. The benchmark analytic approach for estimating program impacts focuses on individuals with observed (non-missing) outcome data, and will statistically adjust for several baseline and location variables to produce credible and precise estimates of program effectiveness. Several sensitivity analyses will be conducted to understand the robustness of the findings across alternative specifications, and to understand the effect of MPC across a variety of subgroups. ;

Study Design

Related Conditions & MeSH terms

Teen Pregnancy Prevention

Clinical Trial Details

NCT number	NCT04863326
Study type	Interventional
Source	Mathematica Policy Research, Inc.
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2017
Completion date	December 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01698073` - Effect of a Culturally-based Intervention on Sexual Risky Behavior Among Young American Indian Adolescents	N/A
Completed	`NCT04508569` - Evaluation of Big Decisions in Three South Texas School Districts	N/A
Completed	`NCT04451031` - Evaluation of the Impact of Linking Families and Teens (LiFT) Curriculum	N/A
Recruiting	`NCT05569070` - Evaluation of Young United Parents	N/A
Completed	`NCT02816424` - Brief Intervention for Teen Pregnancy Prevention	N/A
Recruiting	`NCT03729726` - Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program	N/A
Active, not recruiting	`NCT03419728` - Federal Evaluation of Selected Programs for Expectant and Parenting Youth	N/A
Completed	`NCT02539589` - Evaluation of Becoming a Responsible Teen (BART)	N/A
Active, not recruiting	`NCT04798248` - Evaluation of Momentary Affect Regulation - Safer Sex Intervention	N/A
Completed	`NCT03238313` - Evaluation of "Plan A"	N/A
Completed	`NCT02957669` - Evaluation of Practice Self-Regulation	N/A
Completed	`NCT02544841` - Evaluation of Safer Sex Intervention (SSI)	N/A
Completed	`NCT04181034` - Impacts of the Positive Youth Development Program for Expectant and Parenting Teens in California	N/A
Completed	`NCT03242447` - Evaluation of e-Practice Self-Regulation (e-PS-R)	N/A
Recruiting	`NCT04044027` - Evaluation of the Spark of Duval Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.